CAMP
CAMP4 THERAPEUTICS CORPORATION
4.20
-0.13 (-3.00%)
52w low 2.90
7.75 high
26.8% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Profitability | |||||||
| Operating Margin | -- | -870.3% | -1,655.0% | -3,671.3% | -1,010.1% | -752.1% | |
| EBITDA Margin | -- | -841.5% | -1,602.6% | -3,564.4% | -969.9% | -723.2% | |
| Net Margin | -- | -840.8% | -1,899.2% | -11,575.9% | -1,416.6% | -1,884.8% | |
| FCF Margin | -- | -690.9% | -1,410.9% | 1,808.3% | -848.6% | -720.3% | |
| Returns | |||||||
| Return on Equity | -- | -31.5% | -25.7% | -84.4% | -59.3% | 4,838.4% | |
| Return on Assets | -- | -24.5% | -17.5% | -34.2% | -17.4% | -35.9% | |
| Return on Inv Capital | -- | -25.7% | -17.7% | -21.2% | -33.4% | 1,525.3% | |
| Liquidity | |||||||
| Current Ratio | -- | 5.60x | 9.83x | 7.35x | 6.15x | 4.70x | |
| Quick Ratio | -- | 5.60x | 9.83x | 7.35x | 6.15x | 4.70x | |
| Cash Ratio | -- | 5.32x | 9.52x | 7.06x | 5.97x | 4.51x | |
| Leverage | |||||||
| Debt / Equity | -- | 0.18x | 0.11x | 0.04x | 0.07x | -3.42x | |
| Equity Multiplier | -- | 1.28x | 1.47x | 2.47x | 3.41x | -134.82x | |
| Efficiency | |||||||
| Asset Turnover | -- | 0.03x | 0.01x | 0.00x | 0.01x | 0.02x | |
| Op CF / Net Income | -- | 0.82x | 0.74x | -0.16x | 0.60x | 0.38x | |
| Investment | |||||||
| Capex / Revenue | -- | -- | -- | -- | -- | 7.3% | |
| R&D / Revenue | -- | 690.9% | 1,176.9% | 2,401.4% | 785.2% | 608.0% | |
| SG&A / Revenue | -- | 279.4% | 578.1% | 1,369.8% | 325.0% | 244.1% | |
Revenue CAGR
+4.4%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+37.5%